🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/II trial studies the side effects and best dose of linsitinib ...
Status
Withdrawn
Location
OHSU Knight Cancer Institute
Start Date
2011-12
Trial ID
NCT01465815
The primary objective of this study is to determine if the combination regi...
Status
Terminated
Location
Multiple Locations
Start Date
2011-07
Trial ID
NCT01377376
Treatments Being Tested
This trial was originally designed and powered to compare biomarker modulat...
Status
Completed
Location
University of Pittsburgh Cancer Institute
Start Date
2005-11
Trial ID
NCT01515137
Treatments Being Tested
This ALCHEMIST trial studies genetic testing in screening patients with sta...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-09-26
Trial ID
NCT02194738
Treatments Being Tested
The investigators hypothesized that topical anti-inflammatory treatment cou...
Status
Completed
Location
Davidoff Center, Rabin Medical Center, Beilinson
Start Date
2011-01
Trial ID
NCT01256437
Treatments Being Tested
This phase III ALCHEMIST trial studies how well erlotinib hydrochloride com...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2015-02-11
Trial ID
NCT02193282
This randomized, placebo-controlled, Phase II trial will compare the combin...
Status
Completed
Location
Florida Cancer Specialists
Start Date
2010-01
Trial ID
NCT01027598
This randomized phase II trial is studying how well erlotinib hydrochloride...
Status
Completed
Location
VA Long Beach Healthcare System
Start Date
2008-07
Trial ID
NCT00754494
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Arizona Clinical Research Center
Start Date
2001-10-29
Trial ID
NCT00026338
Treatments Being Tested
This is a Phase III, multicenter, placebo-controlled, double-blind, randomi...
Status
Completed
Location
Kaiser Permanente - Vallejo
Start Date
2005-06-08
Trial ID
NCT00130728
Treatments Being Tested